Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14209, USA.
J Neurosurg. 2011 Jul;115(1):91-100. doi: 10.3171/2011.1.JNS091806. Epub 2011 Mar 18.
The objective of this study was to evaluate endovascular stent therapy for carotid artery dissections (CADs).
Retrospective review of data at Millard Fillmore Gates Hospital identified 43 patients with 44 CADs (intracranial and/or extracranial) treated with carotid artery (CA) stent placement between January 2000 and June 2009.
Thirty-two CADs were spontaneous and 12 were traumatic; 35 were symptomatic. Lesion locations included the extracranial internal CA (ICA; 24 cases), extracranial ICA with common CA involvement (4 cases), and extracranial ICA-intracranial ICA (16 cases). Carotid artery occlusion was 100% in 15 cases (34.1%), 99% in 6 cases (13.6%), 70%-98% in 13 cases (29.5%), and < 70% in 10 cases (22.7%). Five patients suffered pseudoaneurysms. Stent deployment was successful in 43 (97.7%) of 44 cases. The mean pretreatment score on the National Institutes of Health Stroke Scale was 6.2 ± 6.2. Recanalization (Thrombolysis in Myocardial Infarction Grade 2 or 3) was accomplished for 42 lesions (95.5%). Four patients demonstrated residual parent vessel stenosis (10%-50% in severity). Procedure-related complications occurred in 7 patients and included middle cerebral artery embolism (1 patient), intracranial hemorrhage (2 patients), worsening of dissection (1 patient), stent malpositioning (1 patient), embolic protection filter overload (1 patient), and filter retrieval device fracture (1 patient). Only 2 of these complications caused permanent deficits: the embolism caused a minor but permanent neurological deficit, and 1 intracranial hemorrhage was fatal. At discharge, 36 patients (83.7%) had modified Rankin Scale scores of 0-2 (favorable outcome). During the follow-up interval (mean 19.2 months, range 4-92 months), no patient suffered a new stroke and 1 patient died secondary to preexisting chronic renal failure. In 20 patients with angiographic follow-up, permanent resolution of the dissection was noted in 90.5%; 2 lesions (9.5%) required retreatment.
Endovascular stent-assisted repair of extra- and intracranial CAD was safe and effective in this experience and can be recommended for selected patients. In particular, patients with symptomatic CADs that are not responsive to medical therapy should be considered for interventional treatment.
本研究旨在评估颈动脉夹层(CAD)的血管内支架治疗。
对密尔沃基菲尔德·盖茨医院的数据进行回顾性分析,确定了 2000 年 1 月至 2009 年 6 月期间,43 例(颅内和/或颅外)CAD 患者接受颈动脉(CA)支架置入术治疗。
32 例 CAD 为自发性,12 例为外伤性;35 例有症状。病变部位包括颅外颈内动脉(ICA;24 例)、颅外颈内动脉伴颈总动脉受累(4 例)和颅外颈内动脉-颅内颈内动脉(16 例)。15 例(34.1%)颈动脉闭塞 100%,6 例(13.6%)闭塞 99%,13 例(29.5%)闭塞 70%-98%,10 例(22.7%)闭塞 < 70%。5 例患者发生假性动脉瘤。44 例中的 43 例(97.7%)支架置入成功。治疗前 NIH 卒中量表评分平均为 6.2±6.2。42 例(95.5%)再通(心肌梗死溶栓分级 2 或 3 级)。4 例患者存在残余母血管狭窄(严重程度为 10%-50%)。7 例患者发生与操作相关的并发症,包括大脑中动脉栓塞(1 例)、颅内出血(2 例)、夹层恶化(1 例)、支架位置不当(1 例)、栓塞保护滤网过载(1 例)和滤网取回装置断裂(1 例)。只有 2 例并发症导致永久性残疾:栓塞导致轻微但永久性的神经功能缺损,1 例颅内出血导致死亡。出院时,36 例(83.7%)患者改良 Rankin 量表评分为 0-2 分(预后良好)。在随访期间(平均 19.2 个月,范围 4-92 个月),无患者发生新的卒中,1 例患者因原有慢性肾衰竭死亡。在 20 例接受血管造影随访的患者中,90.5%患者的夹层永久性缓解;2 例(9.5%)需要再次治疗。
在本研究中,血管内支架辅助治疗颅外和颅内 CAD 是安全有效的,可推荐用于选择的患者。特别是,对药物治疗反应不佳的有症状 CAD 患者应考虑介入治疗。